Watch video
Testimonial
Follow The Canyon
Stay in touch with The Canyon on Facebook and Twitter. We love to be social. Come join us!
Contact Us
If you prefer, fill out the following form and a counselor will get back to you.
Success Stories
The generosity of the staff and peacefulness of the surroundings has given me a serenity and safety I had never experienced before." - Don
News and Events
Click here to read "Addressing the Complexities of Chronic Pain," by Dr. James Gagne, an internist at The Canyon. The article was published in Marin Medicine Magazine. (This link is provided solely for educational purposes.)
Recent Articles
- Teen Hitman Is Drug Trade’s Latest Casualty
- Grey’s Anatomy Actor Eric Dane Seeks Drug Treatment
- Cocaine’s Colorful History
- Amy Winehouse Found Dead
- U.S. Military Cracks Down On Drug Abuse
- New Report: Cocaine Supply Cut With Flesh-eating Drug
- Does The Social Network Glamorize Drug Use?
- Welfare Drug Testing Debate
- Relapse Lies
- Drug War Woes
Sativex Gains Approval
The U.K. approves the first cannabis-derived drug for use by multiple sclerosis patients. Will it impact the medical marijuana debate in the U.S.?
While the medical marijuana debate rages on in the U.S., a drug made from natural cannabis has become the first of it's kind approved in the world. The United Kingdom's Medicines and Healthcare products Regulatory Agency approved Sativex, an oral spray, just last week and it's already on sale in Great Britain.
The newly-approved prescription-only drug is meant for use by multiple sclerosis patients as it targets the effects of spasticity, a symptom of multiple sclerosis caused by damage to nerves in the central nervous system. These spasms eventually lead to a loss of mobility and involuntary stiffening of muscles in M.S. sufferers.
Sativex Info
Sativex differs from medical marijuana in that it is derived from natural cannabis plant extracts instead of synthetic THC, the active ingredient found in prescription medical marijuana drugs like Marinol, currently approved for use in the U.K. in pill form to treat chemo side effects for cancer patients. Sativex is sprayed into the mouth on the inside of the cheek or under the tongue, according to Bayer Schering Pharma, the pharmaceutical company behind the product.
While Multiple Sclerosis groups in the U.K. supported the approval of the medication, in clinical trials, Sativex only relieved spasms and cramping associated with spasticity for about half of the study participants. That's a positive result, according to the manufacturer.
There is no evidence of long-term dependence or tolerance so Sativex isn't likely to add to the world's growing prescription addiction problem. In fact, many early users say they've been able to reduce their dosage over time.
Sativex is currently in phase II clinical trials for cancer patients in the U.S., but it will likely be several years before it receives FDA approval.
Marijuana Rehab
If you or someone you love is in need of mairijuana rehab, call The Canyon at the toll-free number on our homepage. Someone is there to take your call 24 hours a day and answer any questions you have about treatment, financing or insurance.
If The Canyon isn't right for you, we'll find the place that is.
Articles on Marijuana Rehab
- Treatment for Marijuana Abuse
- Marijuana Being Used for Medicinal Purposes
- Marijuana Rehab and Detox
- Nicknames and Street Names of Marijuana
- What Happens During Marijuana Withdrawal?
- How is Marijuana a Gateway Drug?
- Teens Using Marijuana
- Dangers of Marijuana
- Women and Marijuana Abuse
- Marijuana Rehab Costs
- Marijuana Rehabilitation Intervention
- Marijuana Withdrawal and Treatment
- Los Angeles Marijuana Rehab
- Sativex Gains Approval
- Marijuana and Psychosis
- COPD Risks With Pot